Target Guides to 50 bps Underlying Margin Expansion for FY2026, but Cost Drag Persists

What happened

Target now expects fiscal 2026 underlying operating margin to exceed 2025 by about 50 basis points, driven by anticipated gross margin improvement despite higher SG&A costs. This forward guidance builds on Q1 FY2026 results where comparable sales rose 5.6% and gross margin expanded 80 bps, but the DeepValue report had already highlighted that adjusted SG&A increased year over year due to payroll, incentives, and remodel costs. The new statement implies management believes higher-margin revenue streams such as Roundel, Circle 360, and Target Plus will sufficiently offset the permanent $1.0 billion reinvestment. However, the report's cautious WAIT rating stems from the stock's rich valuation at 20.3x EPS and the need for continued traffic durability, and this guidance provides no detail on the required magnitude of gross margin expansion relative to SG&A deleverage. Without confirmation of sustained comp growth and home category recovery, the margin target may be more aspirational than a reliable catalyst.

Implication

Investors should view the 50 bps underlying margin expansion target as a management assertion that requires validation through sustained comp growth and SG&A leverage. The current price near $155 already embeds a moderate recovery, and a move toward the report's base case $160 leaves limited upside. Key checkpoints remain the August beauty transition, fall home resets, and whether non-merchandise revenue can outpace permanent labor investments. Until we see evidence that gross margin gains are not being consumed by SG&A, the stock is likely range-bound between the attractive entry of $138 and trim level of $170. A failure to deliver on this guidance would intensify the bear case around a higher cost base and stalled operating leverage.

Thesis delta

The new guidance does not fundamentally alter the thesis but slightly strengthens the bull case if credible. Management now commits to a specific margin expansion target, which could attract incremental buyers if execution follows. However, the thesis remains WAIT because the valuation already prices in much of the turnaround, and the guidance lacks detail on the magnitude of required SG&A control and category recovery.